P

Utilizziamo cookie essenziali, di analisi e pubblicitari per migliorare l'esperienza, misurare l'utilizzo e ottimizzare le campagne.

Essenziali

Necessari per il funzionamento del sito e non disattivabili.

Analitici

Ci aiutano a comprendere l'utilizzo per migliorare il servizio.

Pubblicitari

Ci permettono di misurare le campagne e ottimizzare la pubblicità relativa ai nostri servizi.

Maggiori informazioni su Informativa sulla privacy · Termini di Servizio · Cookie Policy

Salva

Open

HORIZON-CL6-2026-01-CIRCBIO-07International

Open

Advancing the European bio-based innovation enabled by biotechnology and biomanufacturing concepts

Horizon Europe

Description

Europe

Health & Life Sciences, Industry•100% • 12M€

Open — Sep 17 (91d)

Dates & Deadlines

Publication Date

Not defined

Opening Date

April 17, 2026

Application Phases

Fase única

September 17, 2026 at 05:00 PM

91 days left

Financial Details

Non-Refundable

Maximum Funding Rate

100%

Budget

12M€

Maximum Duration

48 months

Criteria & Documents

Eligible Expenses

●Personnel Costs
●Equipment costs
●Other goods, works and services costs
●Subcontracting
●Indirect Costs
●Travel and subsistence

Access Conditions

●Legal entities from EU Member States and Associated Countries
●Consortium must include partners from at least three different EU Member States or Associated Countries
●Compliance with general and specific admissibility and eligibility criteria

Selection Criteria

●Excellence (scientific and technical merit)
●Impact (contribution to policy and partnership KPIs)
●Quality and efficiency of implementation

Mandatory Information

●Application form (Part A and Part B)
●Budget

Result Indicators

●Scientific and technical impact
●Innovative biotechnology solutions developed and validated
●Biomanufacturing concepts advanced towards pilot-scale validation
●Resource efficiency improved (biomass, water and energy)

EU Programme Details

Call ID: HORIZON-CL6-2026-01-CIRCBIO-07
Cluster: Food, Bioeconomy, Natural Resources, Agriculture and Environment (Cluster 6)
Destination: D3. Circular economy and bioeconomy sectors
Submission Mode: Single-stage
EU Contribution: Around €4,000,000.00 per project
Expected Projects: 3 projects
Funding Rate Rule: Up to 100% of eligible costs for Research and Innovation Actions (RIA)

Salva

Open

HORIZON-CL6-2026-01-CIRCBIO-07International

Open

Advancing the European bio-based innovation enabled by biotechnology and biomanufacturing concepts

Horizon Europe

Description

Europe

Health & Life Sciences, Industry•100% • 12M€

Open — Sep 17 (91d)

Dates & Deadlines

Publication Date

Not defined

Opening Date

April 17, 2026

Application Phases

Fase única

September 17, 2026 at 05:00 PM

91 days left

Financial Details

Non-Refundable

Maximum Funding Rate

100%

Budget

12M€

Maximum Duration

48 months

Criteria & Documents

Eligible Expenses

●Personnel Costs
●Equipment costs
●Other goods, works and services costs
●Subcontracting
●Indirect Costs
●Travel and subsistence

Access Conditions

●Legal entities from EU Member States and Associated Countries
●Consortium must include partners from at least three different EU Member States or Associated Countries
●Compliance with general and specific admissibility and eligibility criteria

Selection Criteria

●Excellence (scientific and technical merit)
●Impact (contribution to policy and partnership KPIs)
●Quality and efficiency of implementation

Mandatory Information

●Application form (Part A and Part B)
●Budget

Result Indicators

●Scientific and technical impact
●Innovative biotechnology solutions developed and validated
●Biomanufacturing concepts advanced towards pilot-scale validation
●Resource efficiency improved (biomass, water and energy)

EU Programme Details

Call ID: HORIZON-CL6-2026-01-CIRCBIO-07
Cluster: Food, Bioeconomy, Natural Resources, Agriculture and Environment (Cluster 6)
Destination: D3. Circular economy and bioeconomy sectors
Submission Mode: Single-stage
EU Contribution: Around €4,000,000.00 per project
Expected Projects: 3 projects
Funding Rate Rule: Up to 100% of eligible costs for Research and Innovation Actions (RIA)